| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
1.29 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.29 |
Evidence |
O
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
1.29 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
1.29 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.29 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
1.29 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
EPOR |
EPOR: Erythropoietin receptor precursor |
1.29 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.29 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.29 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.29 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.29 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
1.29 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.29 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.29 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
1.29 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
1.29 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
1.29 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
PRLR |
PRLR: Prolactin receptor precursor |
1.29 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
1.29 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.29 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.29 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
1.29 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
1.29 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.29 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.29 |
Evidence |
|